As shown in Figure 7A, exosomes and microvesicles isolated from Japanese—but not from Caucasian—patients with chronic hepatitis C had a strong and long-lasting inhibitory effect on HCV replication during treatment with PEG-IFN-α-based antiviral therapy. The gene discussed is IFNA2; the disease is chronic hepatitis C virus infection.